Identifying patients with Crohn's disease at high risk of primary nonresponse to infliximab using a radiomic‐clinical model

医学 队列 英夫利昔单抗 内科学 接收机工作特性 回顾性队列研究 克罗恩病 临床实习 曲线下面积 疾病 胃肠病学 物理疗法
作者
Xuehua Li,Yingkui Zhong,Chenglang Yuan,Jinjiang Lin,Xiaodi Shen,Minyi Guo,Baolan Lu,Jixin Meng,Yangdi Wang,Naiwen Zhang,Zixin Luo,Guimeng Hu,Ren Mao,Minhu Chen,Canhui Sun,Ziping Li,Qinghua Cao,Baili Chen,Zhihui Chen,Bingsheng Huang,Shi‐Ting Feng
出处
期刊:International Journal of Intelligent Systems [Wiley]
卷期号:37 (12): 11853-11870 被引量:2
标识
DOI:10.1002/int.23066
摘要

Approximately 13%–40% of patients with Crohn's disease (CD) show a primary loss of response to infliximab (IFX) therapy. Therefore, differentiating potential responders from primary nonresponders is clinically important. In this double-center study, we developed and validated a computed tomography enterography (CTE)-based radiomic signature (RS) for identification of CD patients at high risk of primary nonresponse (PNR) to IFX therapy, and demonstrated its incremental value to the clinical model. A total of 244 patients (training cohort, n = 119; test cohort 1, n = 51; test cohort 2, n = 74) were retrospectively recruited. Their clinical data and pretreatment CTE were retrieved and analyzed. All patients underwent IFX induction therapy. Reliability of clinical factors and radiomic-based features were assessed with the area under the receiver operating characteristic curve (AUC). In all, 1130 radiomic features were extracted from the whole inflamed gut in CTE images. In training cohort and test cohorts 1 and 2, the RS that discriminated PNR to IFX therapy yielded AUCs of 0.848, 0.789, and 0.789, respectively (all p < 0.05). By combining the clinical predictors (C-reactive protein, albumin, and body mass index) and RS, the radiomic-clinical model showed an increase in predicting performance (AUCs: 0.864, 0.794, and 0.791, respectively; all p < 0.05). Decision curve analysis and net reclassification improvement demonstrated the clinical usefulness of the radiomic-clinical model. In this study, the proposed RS showed potential as a clinical aid for the accurate identification of CD patients at high risk of PNR to IFX therapy before treatment. A combination of the RS and existing clinical factors might enable a step forward precise medicine.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
田南松发布了新的文献求助10
2秒前
搬砖美少女完成签到,获得积分10
2秒前
nn发布了新的文献求助10
3秒前
7ohnny完成签到,获得积分10
4秒前
apckkk完成签到 ,获得积分10
6秒前
深情安青应助550190946采纳,获得10
7秒前
8秒前
9秒前
jbq完成签到 ,获得积分20
9秒前
YM完成签到,获得积分10
11秒前
生动柔发布了新的文献求助10
11秒前
大旭完成签到 ,获得积分10
12秒前
Fn完成签到 ,获得积分10
14秒前
zero完成签到,获得积分10
16秒前
瘦瘦谷兰完成签到,获得积分10
16秒前
zcz完成签到 ,获得积分10
17秒前
白嘉乐完成签到,获得积分10
18秒前
考研小白完成签到,获得积分10
18秒前
高妍纯完成签到 ,获得积分10
20秒前
22秒前
风中的丝袜完成签到,获得积分10
22秒前
赵赵完成签到,获得积分10
25秒前
25秒前
shiizii应助科研通管家采纳,获得10
26秒前
xuzj应助科研通管家采纳,获得10
26秒前
Mars应助科研通管家采纳,获得30
26秒前
Hello应助科研通管家采纳,获得10
26秒前
叶梓轩完成签到 ,获得积分10
26秒前
上官若男应助科研通管家采纳,获得10
26秒前
26秒前
26秒前
机智的锦程完成签到 ,获得积分10
27秒前
时尚俊驰发布了新的文献求助10
29秒前
华仔完成签到,获得积分10
29秒前
甜甜友容完成签到,获得积分10
33秒前
程哲瀚完成签到,获得积分10
33秒前
33秒前
副本完成签到 ,获得积分10
33秒前
淡然画笔完成签到,获得积分10
34秒前
生动柔完成签到,获得积分20
34秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038201
求助须知:如何正确求助?哪些是违规求助? 3575940
关于积分的说明 11373987
捐赠科研通 3305747
什么是DOI,文献DOI怎么找? 1819274
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022